Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation

Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation

Abstract Urological chronic pelvic pain syndrome (UCPPS) manifests as pelvic pain with frequent urination and has a 10% prevalence rate without effective therapy. Nanoceria (cerium oxide nanoparticles [CNPs]) were synthesized in this study to achieve potential long‐term pain relief, using a commonly...

Full description

Bibliographic Details
Main Authors: Wei‐Chih Lien, Xin‐Ran Zhou, Ya‐Jyun Liang, Congo Tak‐Shing Ching, Chia‐Yih Wang, Fu‐I Lu, Huei‐Cih Chang, Feng‐Huei Lin, Hui‐Min David Wang
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Bioengineering & Translational Medicine
Subjects:
cerium oxide nanoparticle
immunomodulation
SerpinB2
urological chronic pelvic pain syndrome
Online Access:https://doi.org/10.1002/btm2.10346

Internet

https://doi.org/10.1002/btm2.10346

Similar Items